Alliance Highlights the Importance of a Special Registration to Allow Continuity of Care for Patients
The Alliance for Connected Care appreciated the opportunity to testify for the Drug Enforcement Administration's (DEA) listening session on prescribing controlled substances via telemedicine on September 12, 2023. We appreciate the DEA’s quick response during the COVID-19 public health emergency (PHE) to allow prescribing via telemedicine. This was also a hugely meaningful expansion of access [...]